plerixafor has been researched along with Kidney Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, ZL; Gu, C; Gu, JH; Lu, YW; Zou, XF | 1 |
| Dong, W; Hu, X; Jiao, W; Tang, H; Xu, Y; Zeng, S; Zhang, Z | 1 |
| Belizaire, R; Chen, YB; Makar, RS; Spitzer, TR; Sykes, DB | 1 |
| Hu, X; Xu, Y; Xue, W; Zeng, S; Zhang, Q; Zhang, X; Zhang, Z | 1 |
4 other study(ies) available for plerixafor and Kidney Diseases
| Article | Year |
|---|---|
CXC Chemokine Receptor Type 4 Antagonism Ameliorated Allograft Fibrosis in Rat Kidney Transplant Model.
Topics: Allografts; Animals; Benzylamines; Chemokine CXCL12; Collagen Type IV; Cyclams; Disease Models, Animal; Down-Regulation; Fibrosis; Graft Survival; Heterocyclic Compounds; Kidney; Kidney Diseases; Kidney Transplantation; Male; Rats, Inbred F344; Rats, Inbred Lew; Receptors, CXCR4; Signal Transduction; Time Factors; Transforming Growth Factor beta1 | 2017 |
SDF‑1/CXCR4 induces epithelial‑mesenchymal transition through activation of the Wnt/β‑catenin signaling pathway in rat chronic allograft nephropathy.
Topics: Allografts; Animals; Benzylamines; Chemokine CXCL12; Cyclams; Disease Models, Animal; Epithelial-Mesenchymal Transition; Gene Expression Profiling; Heterocyclic Compounds; Immunohistochemistry; Kidney Diseases; Kidney Transplantation; Male; Rats; Receptors, CXCR4; RNA, Long Noncoding; Transplantation, Homologous; Wnt Signaling Pathway | 2019 |
Difficulties in hematopoietic progenitor cell collection from a patient with TEMPI syndrome and severe iatrogenic iron deficiency.
Topics: Benzylamines; Cyclams; Cytapheresis; Erythrocytes, Abnormal; Erythropoietin; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Kidney Diseases; Leukocyte Count; Male; Middle Aged; Paraproteinemias; Polycythemia; Syndrome | 2015 |
CXC Chemokine Receptor 4 (CXCR4) Antagonist, a Novel Pathway to Prevent Chronic Allograft Nephropathy.
Topics: Allografts; Animals; Benzylamines; Creatinine; Cyclams; Disease Models, Animal; Graft Survival; Heterocyclic Compounds; Kidney; Kidney Diseases; Kidney Transplantation; Male; Rats; Rats, Inbred F344; Rats, Inbred Lew; Receptors, CXCR4 | 2016 |